The Kata app from the Munich-based medtech startup Visionhealth is a Class IIa medical device certified app that specifically supports people with chronic lung diseases with inhalation therapy. Correct use of the inhalation device is crucial for therapeutic success. If inhaled incorrectly, less active ingredient reaches the lungs, which can lead to a more severe course of the disease in the long term. Repeated training of patients on the respective inhalation devices is often not possible in practice due to a lack of resources.
This is where the Kata app Using the smartphone camera, the app supports correct inhalation with artificial intelligence (AI), ensuring that the correct dose of medication reaches the lungs. Kata then provides text and image information on how successfully an inhalation was performed. Daily symptom and therapy recordings can also support physicians in making treatment decisions.
“With 100 years of experience in treating lung diseases”
The app is adapted to the most common inhalation devices and, according to Visionhealth, can improve the therapeutic handling of about 75 percent of the devices on the market.
“The innovative Kata app is the ideal complement to Boehringer Ingelheim’s broad inhalation portfolio, ensuring that patients receive optimal support when using their inhalants and that the active ingredients reach the lungs,”
thinks Martin Beck, Head of Human Pharma Germany at Boehringer Ingelheim. And Sabine Häußermann, CEO of Visionhealth, said:
"With 100 years of experience in treating lung diseases, Boehringer Ingelheim is a leader in the field of respiratory diseases. We are excited and proud to work with such a strong partner to market our Kata app in Germany."
